Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K K Ang

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 30, 1993
Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trialL J Peters, H Goepfert, K K Ang, et al.
Cancer|April 3, 2001
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinomaD M Shin, F R Khuri, B S Glisson, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1988
Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicityJ S Kong, L J Peters, J T Wharton, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1990
Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapyC D Wendt, L J Peters, L Delclos, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1982
Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTCK K Ang, E van der Schueren, G Notter, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Cancer|April 1, 1997
Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort studyF B Geara, B S Glisson, G Sanguineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyR Granata, R Miceli, E Orlandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinomaD M Shin, B S Glisson, F R Khuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
International Journal of Radiation Oncology, Biology, Physics|April 30, 1993
Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trialL J Peters, H Goepfert, K K Ang, et al.
Cancer|April 3, 2001
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinomaD M Shin, F R Khuri, B S Glisson, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1988
Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicityJ S Kong, L J Peters, J T Wharton, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1990
Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapyC D Wendt, L J Peters, L Delclos, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1982
Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTCK K Ang, E van der Schueren, G Notter, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Cancer|April 1, 1997
Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort studyF B Geara, B S Glisson, G Sanguineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyR Granata, R Miceli, E Orlandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinomaD M Shin, B S Glisson, F R Khuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Pageof 19